Yepes Manuel
Division of Neuropharmacology and Neurologic Diseases, Yerkes National Primate Research Center; Department of Neurology, Emory University School of Medicine; Department of Neurology, Veterans Affairs Medical Center, Atlanta, GA, USA.
Neural Regen Res. 2022 Nov;17(11):2404-2406. doi: 10.4103/1673-5374.338991.
The repair of injured tissue is a highly complex process that involves cell proliferation, differentiation, and migration. Cell migration requires the dismantling of intercellular contacts in the injured zone and their subsequent reconstitution in the wounded area. Urokinase-type plasminogen activator (uPA) is a serine proteinase found in multiple cell types including endothelial cells, smooth muscle cells, monocytes, and macrophages. A substantial body of experimental evidence with different cell types outside the central nervous system indicates that the binding of uPA to its receptor (uPAR) on the cell surface prompts cell migration by inducing plasmin-mediated degradation of the extracellular matrix. In contrast, although uPA and uPAR are abundantly found in astrocytes and uPA binding to uPAR triggers astrocytic activation, it is unknown if uPA also plays a role in astrocytic migration. Neuronal cadherin is a member of cell adhesion proteins pivotal for the formation of cell-cell contacts between astrocytes. More specifically, while the extracellular domain of neuronal cadherin interacts with the extracellular domain of neuronal cadherin in neighboring cells, its intracellular domain binds to β-catenin, which in turn links the complex to the actin cytoskeleton. Glycogen synthase kinase 3β is a serine-threonine kinase that prevents the cytoplasmic accumulation of β-catenin by inducing its phosphorylation at Ser33, Ser37, and Ser41, thus activating a sequence of events that lead to its proteasomal degradation. The data discussed in this perspective indicate that astrocytes release uPA following a mechanical injury, and that binding of this uPA to uPAR on the cell membrane induces the detachment of β-catenin from the intracellular domain of neuronal cadherin by triggering its extracellular signal-regulated kinase 1/2-mediated phosphorylation at Tyr650. Remarkably, this is followed by the cytoplasmic accumulation of β-catenin because uPA-induced extracellular signal-regulated kinase 1/2 activation also phosphorylates lipoprotein receptor-related protein 6 at Ser1490, which in turn, by recruiting glycogen synthase kinase 3β to its intracellular domain abrogates its effect on β-catenin. The cytoplasmic accumulation of β-catenin is followed by its nuclear translocation, where it induces the expression of uPAR, which is required for the migration of astrocytes from the injured edge into the wounded area.
受损组织的修复是一个高度复杂的过程,涉及细胞增殖、分化和迁移。细胞迁移需要破坏损伤区域的细胞间连接,并在创伤区域重新构建这些连接。尿激酶型纤溶酶原激活剂(uPA)是一种丝氨酸蛋白酶,存在于多种细胞类型中,包括内皮细胞、平滑肌细胞、单核细胞和巨噬细胞。大量针对中枢神经系统以外不同细胞类型的实验证据表明,uPA与其细胞表面受体(uPAR)的结合通过诱导纤溶酶介导的细胞外基质降解来促使细胞迁移。相比之下,尽管在星形胶质细胞中大量发现uPA和uPAR,且uPA与uPAR的结合会触发星形胶质细胞的激活,但尚不清楚uPA是否也在星形胶质细胞迁移中发挥作用。神经元钙黏蛋白是细胞黏附蛋白的成员之一,对星形胶质细胞之间细胞 - 细胞接触的形成至关重要。更具体地说,神经元钙黏蛋白的细胞外结构域与相邻细胞中神经元钙黏蛋白的细胞外结构域相互作用,而其细胞内结构域与β - 连环蛋白结合,β - 连环蛋白进而将该复合物与肌动蛋白细胞骨架相连。糖原合酶激酶3β是一种丝氨酸 - 苏氨酸激酶,通过诱导β - 连环蛋白在Ser33、Ser37和Ser41位点的磷酸化来阻止其在细胞质中的积累,从而激活一系列导致其通过蛋白酶体降解的事件。该观点中讨论的数据表明,星形胶质细胞在机械损伤后释放uPA,并且这种uPA与细胞膜上的uPAR结合会通过触发细胞外信号调节激酶1/2介导的Tyr650位点磷酸化,诱导β - 连环蛋白从神经元钙黏蛋白的细胞内结构域脱离。值得注意的是,随后β - 连环蛋白会在细胞质中积累,因为uPA诱导的细胞外信号调节激酶1/2激活还会使脂蛋白受体相关蛋白6在Ser1490位点磷酸化,这反过来通过将糖原合酶激酶3β招募到其细胞内结构域而消除其对β - 连环蛋白的作用。β - 连环蛋白在细胞质中积累后会发生核转位,在细胞核中它会诱导uPAR的表达,而uPAR是星形胶质细胞从损伤边缘迁移到创伤区域所必需的。